18
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Health and well-being outcomes for drug-dependent offenders on the NSW Drug Court programme

Pages 409-416 | Received 08 Nov 2002, Accepted 31 Jul 2003, Published online: 12 Jul 2009

References

  • Weatherburn D, Topp L, Midford R, Allsopp S. Drug crime prevention and mitigation: a literature review and research agenda. Sydney: New South Wales Bureau of Crime Statistics and Research, 2000.
  • Darke S, Swift W, Hall W. Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 1994;89:211–7.
  • Gossop M, Marsden J, Stewart D, et al. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treat- ment Outcome Research Study. Br J Psychiatry 1998;173:166–71.
  • Webster IM, Waddy N, Jenkins LV, Lai LY. Health status of a group of narcotic addicts in a methadone treatment programme. Med J Aust 1977;2:485–91.
  • Ryan CF, White JM. Health status at entry to methadone maintenance treatment using the SF-36 Health Survey questionnaire. Addiction 1996;91:39–45.
  • Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511–8.
  • Gerstein DR, Lewin LS. Treating drug problems. Volume 1: A study of effectiveness and financing of public and private drug treatment systems. Washington DC: Institute of Medicine, National Academy Press, 1990.
  • Mattick RP, Hall W. A treatment outline for approaches to opioid dependence: quality assurance project. Canberra: Australian Government Publishing Service, 1993.
  • Gossop M, Marsden J, Stewart D, Treacy S. Change and stability of change after treatment of drug misuse: 2-year outcomes from the National Treatment Outcome Research Study (UK). Addict Behav 2002;27:155–66.
  • Bell J, Ward J, Mattick R, Chan J, Hall W. An evaluation of private methadone clinics. Report no. 4. Canberra, 1996.
  • Anglin M, Hser Y. Treatment of drug abuse. In: Tonry M, Wilson JQ, editors. Drugs and crime. Crime and justice: a review of research. Chicago: University of Chicago Press, 1990.
  • Ward J, Mattick R, Hall W. Key issues in methadone maintenance. Sydney: University of New South Wales Press, 1992.
  • Hall W. Methadone maintenance treatment as a crime control measure. Report no. 66. Sydney: New South Wales Bureau of Crime Statistics and Research; 1996.
  • Hall W. The role of legal coercion in the treatment of offenders with alcohol and heroin problem. Aust NZ J Criminol 1997;30:103–20.
  • Freiberg A. Australian drug courts. Crim Law J 2000;24:213–35.
  • Office of Justice Programs Drug Court Clearing House and Technical Assistance Project. Looking at a decade of drug courts. Washington DC: Office of Justice Programs Drug Court Clearing House and Technical Assistance Project, American University, 1999.
  • Office of Justice Programs. Defining drug courts: the key components. Washington DC: US Department of Justice, 1997.
  • Hora P, Schma W, Rosenthal J. Therapeutic jurisprudence and the drug treatment court movement: revolutionizing the criminal justice system’s response to drug abuse and crime in America. Notre Dame Law Rev 1999;74:439–537.
  • Briscoe S, Coumarelos C. New South Wales Drug Court: monitoring report. Report no. 52. Sydney: New South Wales Bureau of Crime Statistics and Research, 2000.
  • Peters RH, Hass AL, Murrin MR. Predictors of retention and arrest in drug courts. Nat Drug Court Inst Rev 1999;2:33–60.
  • Deschenes EP, Turner S, Greenwood PW. Drug Court or probation? An experimental evaluation of Maricopa County’s Drug Court. Justice Syst J 1995;18:55–73.
  • Spohn C, Piper RK, Martin T, Frenzel ED. Drug courts and recidivism: the results of an evaluation using two comparison groups and multiple indicators of recidivism. J Drug Issues 2001;31:149–76.
  • Peters RH, Murrin MR. Effectiveness of treatment-based drug courts in reducing criminal recidivism. Crim Justice Behav 2000;27:72–96.
  • Wolfe WJG, Termondt J. A drug court outcome evaluation comparing arrests in a two year period. J Drug Issues 2002;32:1155–72.
  • Goldkamp JS, Weiland D. Assessing the impact of Dade County’s felony drug court: final report. Philadelphia: PA Crime and Justice Research Institute, 1993.
  • Deschenes EP, Turner S, Greenwood PW, Chiesa J. An experimental evaluation of drug testing and treatment interventions for probationers in Maricopa County, Arizo- na. Unrestricted Draft Series: RAND; 1996 July 1996. Report no. DRU-1387-NIJ.
  • Brewster M. An evaluation of the Chester County (AP) Drug Court Program. J Drug Issues 2001;31:177–206.
  • Freeman K. New South Wales Drug Court evaluation: health, well-being and participant satisfaction. Sydney: New South Wales Bureau of Crime Statistics and Research, 2002.
  • Ware J, Snows K, Kosinski M, Grandek B. SF-36 Health Survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993.
  • Darke S, Ward J, Zador D, Swift G. A scale for estimating the health status of opioid users. Br J Addict 1991;86:1317–22.
  • Adelkan M, Green A, Dasgupta N, Tallack F, Stimson G, Wells B. Reliability and validity of the Opiate Treatment Index among a sample of opiate users in the United Kingdom. Drug Alcohol Rev 1996;15:261–70.
  • Sanson-Fisher R, Perkins J. Adaptation and validation of the SF-36 Health Survey for use in Australia. J Clin Epidemiol 1998;11:961–7.
  • Dobinson I, Ward P. Drugs and crime: a survey of NSW prison property offenders. Sydney: NSW Bureau of Crime Statistics and Research, 1985.
  • ABS. National health survey SF-36 population norms, Australia, 1995. Report No.: Cat. No. 4399.0. Canberra: Australian Bureau of Statistics, 1997.
  • Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol De- pend 2001;62:255–64.
  • Hubbard R, Marsden J, Rachal J, Harwood H, Cavanaugh E, Ginzberg H. Drug abuse treatment: a national study of effectiveness. London: Chapel Hill, 1989.
  • Sells SB, Simpson DD. The case for drug abuse treatment effectiveness, based on the DARP research program. Br J Addict 1980;75:117–31.
  • Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend 1997;47:227–35.
  • Ward J, Mattick RP, Hall W. How long is long enough? Answers to questions about the duration of methadone maintenance treatment. In: Ward J, Mattick RP, Hall W, eds. Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood, 1998:305–36.
  • Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003;98:673–84.
  • Simpson DD, Joe GW, Brown B. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Out- comes Study (DATOS). Psychol Add Behav 1997;11:294–307.
  • Gaughwin M, Solomon P, Ali R. Correlates of retention on the South Australian Methadone Programme 1981-91. Aust NZ J Public Health 1998;22:771–6.
  • Ball JC, Ross A. The effectiveness of methadone main- tenance treatment. New York: Springer, 1991.
  • Caplehorn JR, Lumley TS, Irwig L. Staff attitudes and retention of patients in methadone maintenance programs. Drug Alcohol Depend 1998;52:57–61.
  • Simpson D, Joe GW. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993;30:357–68.
  • Prochaska J, Di Clemente C. Towards a comprehensive model of change. In: Miller WR, Heather N, eds. Treating addictive behaviour: processes of change. New York: Plenum Press, 1986:3–27.
  • Joe GW, Simpson DD, Broome KM. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998;93:1177–90.
  • De Leon G, Jainchill N. Circumstance, motivation, readi- ness and suitability as correlates of treatment tenure. J Psychoact Drugs 1986;18:203–8.
  • Young D, Belenko S. Programme retention and perceived coercion in three models of mandatory drug treatment. J Drug Issues 2002;32:297–328.
  • Anglin D, Brecht M, Maddahian E. Pretreatment char- acteristics and treatment performance of legally coerced versus voluntary methadone maintenance admissions. Criminology 1989;27:537–57.
  • Brecht ML, Anglin MD, Wang JC. Treatment effectiveness for legally coerced versus voluntary methadone maintenance clients. Am J Drug Alcohol Abuse 1993;19:89–106.
  • Broome KM, Knight DK, Knight K, Hiller ML, Simpson DD. Peer, family, and motivational influences on drug treatment process and recidivism for probationers. J Clin Psychol 1997;53:387–97.
  • Belenko S. Research on drug courts: a critical review. Nat Drug Court Inst Rev 1998;1:1–42.
  • Drug court activity update: summary information on all programs and detailed information on adult drug courts: Office of Justice Programs Drug Court Clearinghouse and Technical Assistance Project, 2001.
  • Lawrence R, Freeman K. Design and implementation of Australia’s first drug court. Aust NZ J Criminol 2002;35:63–78.
  • Taplin S. The New South Wales Drug Court evaluation: a process evaluation. Sydney: NSW Bureau of Crime Statistics and Research, 2002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.